Research ArticleCardiovascular
Fetal Rat Hearts Do Not Display Acute Cardiotoxicity in Response to Maternal Doxorubicin Treatment
Mina Mhallem Gziri, Peter Pokreisz, Rita De Vos, Eric Verbeken, Frédéric Debiève, Luc Mertens, Stefan P. Janssens and Frédéric Amant
Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 362-369; DOI: https://doi.org/10.1124/jpet.113.205419
Mina Mhallem Gziri
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology (M.M.G., F.A.), Department of Cardiovascular Sciences (P.P., S.P.J.), Department of Medical Diagnostic Sciences (R.D.V., E.V.), and Department of Cardiology (S.P.J.), University Hospital Leuven, Katholieke Universiteit Leuven, Leuven, Belgium; Department of Obstetrics and Gynaecology, Hopital Saint-Luc, Université Catholique de Louvain, Woluwe, Belgium (F.D.); Division of Imaging and Cardiovascular Dynamics, University of Leuven, Belgium (L.M.); and Division of Cardiology, The Hospital for Sick Children, Toronto, Ontario, Canada (L.M.)
Peter Pokreisz
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology (M.M.G., F.A.), Department of Cardiovascular Sciences (P.P., S.P.J.), Department of Medical Diagnostic Sciences (R.D.V., E.V.), and Department of Cardiology (S.P.J.), University Hospital Leuven, Katholieke Universiteit Leuven, Leuven, Belgium; Department of Obstetrics and Gynaecology, Hopital Saint-Luc, Université Catholique de Louvain, Woluwe, Belgium (F.D.); Division of Imaging and Cardiovascular Dynamics, University of Leuven, Belgium (L.M.); and Division of Cardiology, The Hospital for Sick Children, Toronto, Ontario, Canada (L.M.)
Rita De Vos
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology (M.M.G., F.A.), Department of Cardiovascular Sciences (P.P., S.P.J.), Department of Medical Diagnostic Sciences (R.D.V., E.V.), and Department of Cardiology (S.P.J.), University Hospital Leuven, Katholieke Universiteit Leuven, Leuven, Belgium; Department of Obstetrics and Gynaecology, Hopital Saint-Luc, Université Catholique de Louvain, Woluwe, Belgium (F.D.); Division of Imaging and Cardiovascular Dynamics, University of Leuven, Belgium (L.M.); and Division of Cardiology, The Hospital for Sick Children, Toronto, Ontario, Canada (L.M.)
Eric Verbeken
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology (M.M.G., F.A.), Department of Cardiovascular Sciences (P.P., S.P.J.), Department of Medical Diagnostic Sciences (R.D.V., E.V.), and Department of Cardiology (S.P.J.), University Hospital Leuven, Katholieke Universiteit Leuven, Leuven, Belgium; Department of Obstetrics and Gynaecology, Hopital Saint-Luc, Université Catholique de Louvain, Woluwe, Belgium (F.D.); Division of Imaging and Cardiovascular Dynamics, University of Leuven, Belgium (L.M.); and Division of Cardiology, The Hospital for Sick Children, Toronto, Ontario, Canada (L.M.)
Frédéric Debiève
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology (M.M.G., F.A.), Department of Cardiovascular Sciences (P.P., S.P.J.), Department of Medical Diagnostic Sciences (R.D.V., E.V.), and Department of Cardiology (S.P.J.), University Hospital Leuven, Katholieke Universiteit Leuven, Leuven, Belgium; Department of Obstetrics and Gynaecology, Hopital Saint-Luc, Université Catholique de Louvain, Woluwe, Belgium (F.D.); Division of Imaging and Cardiovascular Dynamics, University of Leuven, Belgium (L.M.); and Division of Cardiology, The Hospital for Sick Children, Toronto, Ontario, Canada (L.M.)
Luc Mertens
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology (M.M.G., F.A.), Department of Cardiovascular Sciences (P.P., S.P.J.), Department of Medical Diagnostic Sciences (R.D.V., E.V.), and Department of Cardiology (S.P.J.), University Hospital Leuven, Katholieke Universiteit Leuven, Leuven, Belgium; Department of Obstetrics and Gynaecology, Hopital Saint-Luc, Université Catholique de Louvain, Woluwe, Belgium (F.D.); Division of Imaging and Cardiovascular Dynamics, University of Leuven, Belgium (L.M.); and Division of Cardiology, The Hospital for Sick Children, Toronto, Ontario, Canada (L.M.)
Stefan P. Janssens
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology (M.M.G., F.A.), Department of Cardiovascular Sciences (P.P., S.P.J.), Department of Medical Diagnostic Sciences (R.D.V., E.V.), and Department of Cardiology (S.P.J.), University Hospital Leuven, Katholieke Universiteit Leuven, Leuven, Belgium; Department of Obstetrics and Gynaecology, Hopital Saint-Luc, Université Catholique de Louvain, Woluwe, Belgium (F.D.); Division of Imaging and Cardiovascular Dynamics, University of Leuven, Belgium (L.M.); and Division of Cardiology, The Hospital for Sick Children, Toronto, Ontario, Canada (L.M.)
Frédéric Amant
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology (M.M.G., F.A.), Department of Cardiovascular Sciences (P.P., S.P.J.), Department of Medical Diagnostic Sciences (R.D.V., E.V.), and Department of Cardiology (S.P.J.), University Hospital Leuven, Katholieke Universiteit Leuven, Leuven, Belgium; Department of Obstetrics and Gynaecology, Hopital Saint-Luc, Université Catholique de Louvain, Woluwe, Belgium (F.D.); Division of Imaging and Cardiovascular Dynamics, University of Leuven, Belgium (L.M.); and Division of Cardiology, The Hospital for Sick Children, Toronto, Ontario, Canada (L.M.)
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleCardiovascular
Acute Doxorubicin Cardiotoxicity
Mina Mhallem Gziri, Peter Pokreisz, Rita De Vos, Eric Verbeken, Frédéric Debiève, Luc Mertens, Stefan P. Janssens and Frédéric Amant
Journal of Pharmacology and Experimental Therapeutics September 1, 2013, 346 (3) 362-369; DOI: https://doi.org/10.1124/jpet.113.205419
Research ArticleCardiovascular
Acute Doxorubicin Cardiotoxicity
Mina Mhallem Gziri, Peter Pokreisz, Rita De Vos, Eric Verbeken, Frédéric Debiève, Luc Mertens, Stefan P. Janssens and Frédéric Amant
Journal of Pharmacology and Experimental Therapeutics September 1, 2013, 346 (3) 362-369; DOI: https://doi.org/10.1124/jpet.113.205419
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement